Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine for Postoperative Analgesia in Breast Reconstruction
NCT04278846Phase 4Completed
- Sponsor
- Cleveland Clinic
- Start
- Aug 2014
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Cleveland Clinic. Primary endpoints: Pain Assessment Numeric Rating Scale During Rest at 96 hours, Pain Assessment Numeric Rating Scale During Activity at 96 hours and 2 more. Started Aug 2014; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04278846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04278846.